Test ID ECHNO Echinococcus Antibody, IgG, Serum

Useful For
Detection of antibodies to Echinococcus species, including E multilocularis and E granulosus
Method Name
Enzyme Immunoassay (EIA)
Reporting Name
Echinococcus Ab, IgG, SSpecimen Type
SerumContainer/Tube:
Preferred: Serum gel
Acceptable: Red top
Specimen Volume: 0.50 mL
Specimen Minimum Volume
0.20 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Serum | Refrigerated (preferred) | 30 days |
Frozen | 30 days |
Clinical Information
Echinococcosis, also referred to as hydatidosis or hydatid disease, is one of the 17 neglected tropical diseases recognized by the World Health Organization, and affects over 1 million people worldwide. Echinococcus species are tapeworms or cestodes and 2 main species infect humans: Echinococcus granulosus and Echinococcus multilocularis.
With respect to geographic distribution, E granulosus can be found worldwide, but more frequently in rural, grazing areas where dogs may feed on deceased,infected sheep or cattle. E multilocularis is largely localized to the northern hemisphere. The definitive hosts for E granulosus are dogs or other canids, while the definitive host for E multilocularis are foxes and, to a much lesser extent, canids. Echinococcus tapeworms reside in the small intestine of definitive hosts and release eggs that are passed in the feces and ingested by an intermediate host, typically sheep or cattle in the case of E granulosus or small rodents for E multilocularis. The eggs hatch in the small bowel, releasing an oncosphere, which penetrates the intestinal wall and migrates through the circulatory system to various organs where it will develop into a cyst that gradually enlarges producing protoscolicies and daughter cysts that fill the interior. The definitive host becomes infected following ingestion of these infectious cysts. Humans become accidentally infected following ingestion of Echinococcus eggs.
In humans, E granulosus (cystic echinococcal disease) cysts typically develop in the lungs and liver and the infection may remain silent or latent for years (5-20 years) prior to cyst enlargement and symptom manifestation. Symptomatic manifestations include chest pain, hemoptysis and cough for pulmonary involvement and abdominal pain and biliary duct obstruction for liver infection. E multilocularis (alveolar echinococcal disease) infections manifest more rapidly than those of E granulosus, and manifests similar to a rapidly growing, destructive tumor resulting in abdominal pain and biliary obstruction. Rupture of cysts can produce fever, urticaria and anaphylactic shock.
Diagnosis of echinococcal infections relies on characteristic finding by ultrasound or other imaging techniques and serologic findings. Fine needle aspirates of cystic fluid may be performed; however they carry the risk of cyst puncture and fluid leakage which may potentially lead to severe allergic reactions. Importantly, infected individuals do not shed eggs in stool.
Reference Values
Negative
Cautions
Depending on cyst location, individuals may not develop high enough antibody titers to be detectable by serologic assays, leading to false-negative results. Cysts localized to the lungs, central nervous system or spleen, or cysts that are senescent, calcified, or dead are associated with lower serologic reactivity.
False-positive results may occur in patients with other helminth infections, including with Taenia species, Schistosoma species, and Strongyloides. Careful correlation with imaging findings and exposure history is required.
This assay may not detect antibodies to other species of Echinococcus, including E vogeli and E oligarthrus, both fairly uncommon causes of hydatid disease in humans.
Day(s) Performed
Tuesday, Thursday; 9 a. m.
Report Available
Same day/1 dayPerforming Laboratory

Test Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
86682